Neuroscience Abbisko and Sperogenix Announce an Exclusive Agreement to Develop ABSK021 for ALS and Other Rare… AIT News Desk Jul 6, 2021 Sperogenix MedTech Co., Ltd., a subsidiary of Sperogenix Therapeutics, has entered into an exclusive licensing agreement with Abbisko Therapeutics…